Camargo, A Division of Premier Research

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology

Accelsiors is a scientifically-driven, global, full-service Contract Research Organization (CRO). We support the Pharma industry globally to accelerate and manage every activity across clinical drug development.

Since 2002, we have been committed to providing Sponsors working in highly complex disease indications with the scientific knowledge, regulatory expertise and quality operations necessary to achieve their development objectives.

Accelsiors expertise includes studies in the following areas:

• Biosimilars
• Complex Generics
• Hepatology
• Infectious Disease
• Inflammatory Disease
• Nephrology
• Neurology
• Oncology
• Pulmonary
• Rare Diseases
• Rheumatology

We serve a global Customer base, which ranges from emerging biotechnology companies to multi-national pharmaceutical companies.

Accelsiors is committed to establishing meaningful collaborations with our Sponsors and executing studies, regardless of size and scope, with quality being the key driver in all that we do.

Camargo Pharmaceutical Services is a leading global strategy, regulatory, and development partner for emerging to mid-size biopharma. We specialize in complex drug development programs where no playbook exists, with integrated solutions spanning from product concept to commercial stages that enable sponsors to reach milestones with speed and capital efficiency.

We have experience in rare and accelerated approval pathways, specialty populations, and innovative science including orphan drugs, the 505(b)(2) pathway, oncology, neurology, pediatrics, combination products, and digital therapeutics. We are proud to support clients in more than 35 countries around the world.

CLINITRIA Ltd. is regionally respected, dynamic and very flexible CRO established by experienced professionals with many years of experience in pharmaceutical development and biomedical research in Western Europe. Company was established in 1995 and it is fully specialized in clinical research since 2002.

CLINITRIA is member of SACROP (Slovak Association of Clinical Research Organizations and Professionals) and EUCROF (European CRO Federation).

CLINITRIA operates in the following Central European countries: Czech republic, Slovakia, Poland, Hungary, Austria and Slovenia. At present we are extending our activities to Romania, Bulgaria and other non-EU Eastern European countries like Serbia, Croatia, and Ukraine, which have relatively short regulatory and EC timelines.

CLINITRIA is able to identify and contract investigators for clinical trials for Phase I - IV studies, identify and contract Pre-clinical Units, perform study setup, monitoring or auditing of clinical trials. We are able to organize investigator meetings and scientific congresses/symposia. Local knowledge is our strong advantage, which allows us selecting the best recruiting investigators, shortening study timelines and obtaining high quality data.

Clinical areas of expertise: cardiology, cardiosurgery, neurology, neurosurgery, psychiatry, oncology, ophthalmology, gastroenterology, endocrinology, rheumatology, pulmonary hypertension, male fertility/erectile dysfunction, etc. We have experience in medical devices studies.

Our activities are strictly based on ICH-GCP guidelines, new EU directives, local legislation and ethical principles.

DP Clinical, Inc. is a privately held Contract Research Organization (CRO) specializing in neurology/CNS (including spinal cord injury), oncology, ophthalmology, infectious disease/vaccines, and rare disease Phase I-IV clinical programs. DP Clinical provides a full complement of clinical trial services to pharmaceutical, biotech, and medical device companies including trial management, monitoring, data management, biostatistics, regulatory, safety monitoring and reporting, and medical writing. Since 1994, we have worked for clients of all sizes — small to large pharmaceutical and biotech companies, academic research institutions, and government sponsors.

DP Clinical provides integrated trial solutions as well as specific service components based on sponsor need. Our comprehensive services include:
• Project management
• Clinical trial monitoring
• Data management
• Biostatistics
• Pharmacovigilance and safety
• Regulatory affairs
• Quality assurance
• Medical writing